Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06275919
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-02-07
Brief Title:
Regorafenib for Recurrent Grade 2 and 3 Meningioma MIRAGE Trial
Sponsor:
Istituto Oncologico Veneto IRCCS
Organization:
Istituto Oncologico Veneto IRCCS
Organization Data
Organization:
Istituto Oncologico Veneto IRCCS
Class:
OTHER
Study ID:
IOV-BT-1-2023 MIRAGE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istituto Oncologico Veneto IRCCS
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |